Navigation Links
China Nepstar Chain Drugstore Acquires Drugstores in Beijing
Date:7/13/2009

SHENZHEN, China, July 13 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, today announced that it has entered into a definitive agreement with Beijing Run Ze Tang Drugstore, to acquire its five drugstores in Beijing. This acquisition represents China Nepstar's first retail presence in Beijing, one of the most important markets in China in terms of store traffic and consumption power. The five stores being acquired have an average store size of 170 square meters, and are located in densely populated residential areas in Beijing. Closing of the acquisition is expected to be in August. The stores will be serviced by the Company's regional logistics center in Tianjin, where Nepstar has over 100 stores. Tianjin is approximately 120km to the southeast of Beijing.

Beijing is the capital city of China and one of the four municipalities under the jurisdiction of the central government. Beijing's per capita GDP amounted to RMB63,000 in 2008. At the end of 2008, Beijing had a total residential population of approximately 14 million, and a large number of visitors from China and worldwide. An average Beijing resident enjoyed a disposable income of RMB24,700 in 2008, higher than their counterparts in other affluent regions of mainland China.

Mr. Ian Wade, Co-Chief Executive Officer of China Nepstar, commented, "This acquisition represents the initial step for China Nepstar to enter into the Beijing market, which we believe to have significant development potential. This is also our first chance to showcase Beijing customers our wide product offerings and advanced store management. We plan to continue to expand in Beijing through gradual ramp-up in new store openings and high quality acquisitions."

About China Nepstar Chain Drugstore Ltd.

China Nepstar Chain Drugstore Ltd. (NYSE: NPD) is China's largest retail drugstore chain based on the number of directly operated stores. As of March 31, 2009, the Company had 2,336 stores across 63 cities and 361 stores of its affiliate in Yunnan province, which ceased to be the Company's subsidiary in January 2009, one headquarter distribution center and 12 regional distribution centers in China. Nepstar uses directly operated stores, centralized procurement and a network of distribution centers to provide its customers with high-quality, professional and convenient pharmacy services and a wide variety of other merchandise, including OTC drugs, nutritional supplements, herbal products, personal care products, family care products, and convenience products including consumables. Nepstar's strategy of centralized procurement, competitive pricing, customer loyalty programs and private label offerings has enabled it to capitalize on the robust economic growth in China and to take advantage of the demographic trend in China to achieve a strong brand and leading market position. For further information, please go to http://www.nepstar.cn .

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release and the Company's strategic operational plans and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

    Contacts

    In China:
     Lucia Qian
     China Nepstar Chain Drugstore Ltd.
     Marketing and IR Director
     Tel:   +86-755-2641-4065
     Email: qianrt@nepstar.cn

    In the United States:
     Dixon Chen
     Grayling
     Investor Relations
     Tel:   +1-646-284-9403
     Email: Dixon.chen@us.grayling.com

     Ivette Almeida
     Grayling
     Media Relations
     Tel:   +1-646-284-9455
     Email: ivette.almeida@us.grayling.com

'/>"/>
SOURCE China Nepstar Chain Drugstore Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Medicine Receives Approval for a RMB 20 Million Loan
2. Perot Systems Selected to Implement Health Information Systems in China
3. Perot Systems Launches Website in Chinese to Support Expansion Into China
4. Winner Medical Signs PurCotton Sales Agreement With Consumer Products Leader in China
5. Tianyin Pharmaceutical Co., Inc. Launches Advertising Program on China Central Television (CCTV) for its Xuelian Chongcao Oral Liquid
6. Opening Day of Fi Asia-China 2009 Brings the Food Ingredients Industry to Shanghai
7. China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch
8. China Pharma Holdings, Inc. Announces SFDA Approval for Rosuvastatin Clinical Trials
9. Winner Medical to Benefit From the Increase of Tax Rebate Rate for Exports From China
10. China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31, 2009
11. Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... Celiac Association (CCA), is pleased to announce the launch of the GFCP ... articles, recipes, and more. The purpose of the GFCP Scoop site ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
(Date:4/29/2016)... ... April 29, 2016 , ... CURE ... entirely on patients with cancer, today announced that Lynne Malestic, RN, of Eisenhower ... 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses who have ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... to promote their animal line of probiotics, Petbiotics ™, as they fondly ... turnout of animal rescue groups networking for their non-profit organizations. Animal rescues across ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
(Date:4/28/2016)... 28, 2016 ... Phillips und Stephen Schmidt ... ArisGlobal®, ein führender Anbieter cloudbasierter Softwarelösungen ... bekannt, dass neue Führungskräfte zum Team Sicherheit ... die vielfältige Erfahrungen mitbringen.  Dies wird die ...
(Date:4/28/2016)... April 28, 2016 , Net Sales of ... basis over the prior year period, and an increase of ... , Diluted EPS for the first quarter were $0.52 reported, ... $2.00 adjusted, an increase of 29.9% over the prior year ... adjusted earnings guidance for 2016 Zimmer Biomet Holdings, ...
Breaking Medicine Technology: